This large case-control study further supports the hypothesis that the T2D risk contribution of ENPP1, ADIPOQ, PPARG and TCF7L2 SNPs may be modulated by obesity status [6-8,11]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.